Seebacher et al. demonstrated that Pgp-expressing tumor cells, normally unresponsive to Doxorubicin, were efficiently killed when treated with Dp44mT or DpC (Figure 9A,B) [9,178]. This evidence concerns the gene PGP and neoplasm.